Filtered By:
Therapy: Chemotherapy
This page shows you your search results in order of date.
Order by Relevance | Date
Total 944 results found since Jan 2013.
A pediatric case series of catastrophic gastrointestinal complications of posttransplant lymphoproliferative disease with increasing incidence, high association with coronavirus disease 2019, higher mortality, and a plea for early endoscopy to prevent late fatal outcome
ConclusionSince 80% of our patients had exposure to coronavirus, a potential relationship might be suggested between the two. Furthermore, as we witnessed in one case, urgent endoscopic investigation in immunocompromised patients presenting with gastrointestinal symptoms can improve the clinical outcomes and therefore should be considered for early diagnosis of posttransplant lymphoproliferative disorder.
Source: Journal of Medical Case Reports - September 19, 2023 Category: General Medicine Source Type: research
Pediatric cancer care management during the COVID-19 pandemic: a review of the literature and a single-centre real-life experience of an Italian pediatric oncology unit
In conclusion, we reported the real-life experience of our pediatric oncology unit during the pandemic period.EXPERT OPINION: Starting from the data available in literature, and our experience, showing the rarity of severe COVID-19 disease in pediatric patients with solid tumors, we recommend carefully tailoring all the oncological treatments (chemotherapy/targeted therapy/stem cell transplantation/radiotherapy). The aim is the preservation of the treatment's timing, balanced with an evaluation of possible severe COVID-19 disease.PMID:37712347 | DOI:10.1080/14737140.2023.2245148
Source: Expert Review of Anticancer Therapy - September 15, 2023 Category: Cancer & Oncology Authors: Olga Nigro Chiara Oltolini Federica Barzaghi Caterina Uberti Foppa Maria Pia Cicalese Maura Massimino Elisabetta Schiavello Source Type: research
Experience with the safe admission of breast and thyroid cancer patients in non-endemic areas during an epidemic outbreak
ConclusionThe spread and cross-infection of COVID-19 can be avoided in non-hotspot epidemic areas based on scientific prevention and control, and cancer patients can be diagnosed and treated on time. The prevention and control measure implemented in the COVID-19 epidemic for diagnosing and treating cancer patients was effective and can be referenced for other infectious disease outbreaks.
Source: Frontiers in Oncology - September 13, 2023 Category: Cancer & Oncology Source Type: research
The Impact of COVID19 on Treatment Practices for Patients With Early Breast Cancer: A Cross-Sectional Study From a Large Cancer Center In Italy
CONCLUSIONS: There was no evidence for major changes in the management of patients with EBC during 2019-2021 and no treatment delays were observed. Our findings suggest that more women presented with palpable nodules at diagnosis, but the stage distribution did not change over time. Validation on a larger cohort of patients is warranted to robustly assess the impact of the COVID19 pandemic on treatment practices for patients with EBC.PMID:37699107 | DOI:10.1093/oncolo/oyad255
Source: The Oncologist - September 12, 2023 Category: Cancer & Oncology Authors: Fabio Girardi Sabrina Marini Francesca Porra Sonia Carpentieri Alberto Marchet Tania Saibene Marcello Lo Mele Tommaso Giarratano Carlo Alberto Giorgi Eleonora Mioranza Cristina Falci Giovanni Faggioni Francesca Caumo Gaia Griguolo Maria Vittoria Dieci Val Source Type: research
Comparable efficacy and safety of COVID-19 vaccines for patients receiving tegafur –uracil as postoperative adjuvant chemotherapy
ConclusionsThe efficacy and safety of the SARS-CoV-2 vaccines for NSCLC patients who received postoperative adjuvant UFT chemotherapy were comparable to those for NSCLC patients who did not receive postoperative adjuvant UFT chemotherapy.Clinical trial registrationThis study was registered with the University Hospital Medical Information Network (UMIN) in Japan (UMIN000047380).
Source: Surgery Today - September 1, 2023 Category: Surgery Source Type: research
Viruses, Vol. 15, Pages 1759: Dynamic Evolution of SARS-CoV-2 in a Patient on Chemotherapy
We report here a case of B-cell acute lymphocytic leukemia on chemotherapy with infection of SARS-CoV-2 for more than two months. Genomic surveillance of his serial SARS-CoV-2-positive specimens revealed two unprecedented large deletions, Δ15–26 and Δ138–145, in the viral spike protein N-terminal domain (NTD) and demonstrated their dynamic shifts in generating these new variants. Located at antigenic supersites, these large deletions are anticipated to dramatically change the spike protein NTD in three-dimensional protein structure prediction, which may lead to immune...
Source: Viruses - August 18, 2023 Category: Virology Authors: Weihua Huang Changhong Yin Kimberly P. Briley William A. B. Dalzell John T. Fallon Tags: Communication Source Type: research
Mucormycosis and Its Upsurge During COVID-19 Epidemic: An Updated Review
Curr Microbiol. 2023 Aug 17;80(10):322. doi: 10.1007/s00284-023-03430-w.ABSTRACTAlthough mucormycosis may have reached an epidemic situation during the COVID-19 pandemic, the term was much more familiar even before the COVID-19 period. The year 2020 showed an outbreak of novel coronavirus (SARS-CoV-2) which affected millions of people all over the world. One of the noticeable complications observed to be associated with this disease is mucormycosis. It is an opportunistic infection caused by members of the Order Mucorales existing worldwide and has been commonly reported as a laboratory contaminant for a long time. However...
Source: Current Microbiology - August 17, 2023 Category: Microbiology Authors: Bharti Sharma Skarma Nonzom Source Type: research
Effect of dapagliflozin on COVID-19 infection and risk of hospitalization
ConclusionsUse of dapagliflozin prior to SARS-CoV-2 infection was not associated with an increased risk of hospitalization, ICU admission, mortality or progression to severe COVID-19. However, it was associated with an increased risk of susceptibility to COVID-19 infection.
Source: Journal of Antimicrobial Chemotherapy - August 7, 2023 Category: Microbiology Source Type: research
The impact of the Covid 19 pandemic in colorectal cancer
CONCLUSIONS: In this study, it was seen that the COVID-19 pandemic did not affect morbidity and mortality in CRC surgery, but it prolonged admission waiting and operation waiting times. Since there is very little data in the literature regarding the effect of COVID-19 on CRC surgery, our study will guide future studies on this subject.KEY WORDS: Colorectal Cancer, Coronavirus disease 2019, COVID-19, Surgery.PMID:37530050
Source: Annali Italiani di Chirurgia - August 2, 2023 Category: Surgery Authors: Afig Gojayev Cemil Yuksel Ogun Ersen Umit Mercan Haydar Celasin Ali Ekrem Unal Salim Demirci Source Type: research
